Profound impairment in cellular oxygen consumption, referred to as cytopathic dysoxia, is one of the pathological hallmarks in the lungs of patients with pathogen-induced acute lung injury (ALI). However, the underlying mechanism for this functional defect remains largely unexplored. In this study, we found that primary mouse alveolar epithelial cells (AECs) conducted robust fatty acid oxidation (FAO). More importantly, FAO was strikingly impaired in AECs of mice with LPS-induced ALI. The metabolic deficiency in these cells was likely due to decreased expression of key mediators involved in FAO and mitochondrial bioenergenesis, such as peroxisome proliferator-activated receptor g coactivator (PGC)-1a, carnitine palmitoyltransferase 1A, and medium-chain acyl-CoA dehydrogenase (CAD). We found that treatment of alveolar epithelial line MLE-12 cells with BAL fluids from mice with ALI decreased FAO, and this effect was largely replicated in MLE-12 cells treated with the proinflammatory cytokine TNF-a, which was consistent with downregulations of PGC-1a, carnitine palmitoyltransferase 1A, long-chain CAD, and medium-chain CAD in the same treated cells. Furthermore, we found that the BAL fluids from ALI mice and TNF-a inhibited MLE-12 bioenergenesis and promoted cell apoptosis. In delineation of the role of FAO in ALI in vivo, we found that conditional ablation of AEC PGC-1a aggravated LPS-induced ALI. In contrast, fenofibrate, an activator of the PPAR-a/PGC-1a cascade, protected mice from this pathology. In summary, these data suggest that FAO is essential to AEC bioenergenesis and functional homeostasis. This study also indicates that FAO impairment-induced AEC dysfunction is an important contributing factor to the pathogenesis of ALI.
Among pathological hallmarks of acute lung injury (ALI), there is a profound impairment in cellular oxygen consumption, called cytopathic dysoxia, and a proinflammatory cytokine storm produced by immune cells, such as neutrophils and macrophages (1) (2) (3) (4) (5) (6) (7) . The cytopathic dysoxia is thought to be resulted from abnormalities of mitochondria, as they are the primary oxygen-consuming subcellular organelles (1, 3, 4, (8) (9) (10) (11) . Persistent defects in mitochondrial bioenergetics leads to cell death, which contributes to the pathogenesis of ALI (8, 12) . However, the molecular mechanism underlying the cytopathic dysoxia in ALI is largely unknown.
Alveolar epithelial cells (AECs), together with pulmonary microvascular endothelial cells, form the blood-air barrier that is essential to gas exchange and pulmonary fluid homeostasis (13) (14) (15) . Dysfunctions of AECs have been well recognized to be important contributing factors to ALI pathologies, such as destruction of alveolar barriers, accumulation of pulmonary fluids, and decreased production of surfactants (13) (14) (15) (16) (17) . However, the mechanisms underlying these AEC abnormalities are incompletely understood.
Glucose and fatty acids are the primary bioenergetic sources for mammalian cells. Whereas almost all types of cells prefer glucose, skeletal myocytes, cardiomyocytes, hepatocytes, and adipocytes mainly oxidize fatty acids in mitochondria to fuel ATP production, a process termed fatty acid oxidation (FAO) (18) (19) (20) (21) (22) . Nevertheless, it has been unclear what bioenergetic nutrients AECs use in resting state, and how these metabolic programs are affected under stressful settings.
The pivotal mitochondrial regulator, peroxisome proliferator-activated receptor (PPAR) g coactivator (PGC)-1a, promotes FAO by inducing critical mediators in this metabolic process, including carnitine palmitoyltransferase I (CPT1), a key enzyme that mediates transportation of fatty acids across mitochondrial membrane into matrix (18, 23, 24) . Once inside the mitochondria, fatty acids undergo a series of reactions, including acyl-CoA dehydrogenase (CAD)-mediated dehydrogenation, hydration, oxidation, and thiolysis for acetyl-CoA production to fuel the citric acid cycle (19, 25) . Very long chain fatty acids are first oxidized in peroxisomes (peroxisomal FAO), with acyl-coenzyme A oxidase 1 being the first enzyme. This process results in length reduction of the very long chain fatty acids before they can be processed in mitochondria (26) .
In this study, we found that AECs conduct robust FAO, and this metabolic program was remarkably reduced in AECs of mice with LPS-induced ALI. We found that impairment of FAO diminished AEC bioenergenesis and rendered the cells susceptible to apoptosis. Our data suggest that FAO impairment leads to AEC dysfunctions that contributes to ALI pathogenesis.
Methods

Reagents
Ultrapure LPS from Escherichia coli O111: B4, palmitic acid, fenofibrate, and fatty acid-free BSA were purchased from SigmaAldridge. Etomoxir (ETO) was from Cayman Chemical. Mouse recombinant TNF-a was from Peprotech.
Cell Line
The mouse AEC line, MLE-12, and HEK-293T cells were purchased from the (A-C) n = 3 for the saline and LPS groups, respectively; mean 6 SEM; *P , 0.05, ***P , 0.001. (D) The expression of the indicated genes in total lungs was determined by realtime PCR. n = 5 for the saline and LPS groups, respectively; mean 6 SEM; **P , 0.01, ***P , 0.001. PGC-1a = peroxisome proliferator-activated receptor g coactivator-1a.
American Type Culture Collection and cultured according to the their instructions.
Generation of Conditional Knockout Mice with Ablation of PGC-1a in AECs
To generate AEC PGC-1a 2/2 mice, Ppargc1a floxed mice (PGC-1a fl/fl ; stock #009666; The Jackson Laboratory) were cross-bred with Sftpc-CreER T2 mouse line (stock #028054; The Jackson Laboratory) to obtain mice with Ppargc1a /Sftpc-CreER T21/2 genotype. To induce AEC PGC-1a deletion, these mice (at age 10 wk) were injected intraperitoneally with tamoxifen dissolved in corn oil (75 mg/kg body weight) once a day for 5 days. PGC-1a fl/fl mice that received the same dosage of tamoxifen were used as controls. At 3 days after the last intraperitoneal injection, the mice were used for ALI experiments. C57BL/6 male mice (8 wk old) were also purchased from The Jackson Laboratory. The animal protocol was approved by the UAB Institutional Animal Care and Use Committee.
RNA Sequencing Assay
RNA sequencing (RNA-seq) was performed by Arraystar Inc. RNA-seq data were submitted to the Gene Expression Omnibus and are unrestrictedly accessible with accession number GSE109913 (available AECs use both glucose and fatty acids, and FAO is impaired in AECs of mice with LPS-induced ALI. (A) Primary AECs were seeded in Seahorse XF-24 microplates and incubated with substrate-limited media for 3 hours. Basal oxygen consumption rate (OCR) was then recorded before BSA or palmitate-BSA (final concentration: 150 mM) was injected into the wells. After injection, OCR was continuously monitored until it reached the maximum value. n = 4 per group; mean 6 SEM. (B) Primary AECs were seeded in Seahorse XF-24 microplates and incubated with extracellular acidification rate (ECAR) media for 1 hour. Basal OCR and ECAR were then recorded before glucose (final concentration: 10 mM) was injected into the wells. After injection, OCR and ECAR were continuously monitored until they reached the maximum values. n = 3 per group; mean 6 SEM. (C) Primary AECs purified from saline or intratracheal LPS-treated mice were seeded in Seahorse XF-24 microplates and incubated with substrate-limited media for 3 hours. Basal OCR was then recorded before palmitate-BSA was injected into the wells. After injection, OCR was continuously monitored until it reached the maximum value. OCR values were normalized to total protein content of the cellular extract from each well. n = 4 mice per group; mean 6 SEM.
online at https://www.ncbi.nlm.nih. gov/geo/query/acc.cgi?acc=GSE109913).
Establishment and Evaluation of LPS-induced ALI
Mice were instilled intratracheally LPS (2 mg/kg in 50 ml saline). At 24 hours after treatment, mice were killed and the following assays were performed to evaluate severity of lung injury: determination of BAL fluid (BALF) leukocyte numbers and protein concentrations; determination of BALF and lung proinflammatory cytokine levels; lung histological evaluation.
Isolation of Mouse AECs
Lungs were minced and incubated with digestion buffer (Hank's Balanced Salt Solution, containing 0.1% type I collagenase, 0.1% dispase II, and 0.01% DNase I) for 1 hour at 37 8 C. Single-cell suspensions were prepared by passing the lung digestions through a 40-mm mesh size cell strainer. The cells were then pelleted and red blood cell lysed. Primary AECs were obtained by subjecting the singlecell suspensions to a negative selection by incubation with biotin-conjugated anti-CD16/32, -CD45, -CD31, -CD90, -Ter119, and -PDGFR-a antibodies (BD Basal OCR was then recorded before BSA or palmitate-BSA was injected into the wells. After injection, OCR was continuously monitored until it reached the maximum value. n = 5 or 6 for the palmitate-BSA or BSA group; mean 6 SEM. (B) MLE-12 cells were seeded in Seahorse XF-24 microplates and treated with saline or 100 mM etomoxir (ETO) for 1 hour. The media were then replaced with FAO assay media supplemented with 150 mM palmitate-BSA and cultured for 1 hour, followed by sequential treatments with 3 mg/ml oligomycin (Oligo), 6 mM FCCP, and 1 mM rotenone (Rot) and 0.5 mM antimycin A (Ant). Real-time OCR was recorded. n = 6 or 5 for the saline or ETO group; mean 6 SEM. (C) MLE-12 cells were seeded in Seahorse XF-24 microplates and incubated with ECAR media for 1 hour. Basal OCR and ECAR were then recorded before glucose (final concentration: 10 mM) was injected into the wells. After injection, OCR and ECAR were continuously monitored until they reached the maximum values. n = 7; mean 6 SEM. (D) MLE-12 cells were seeded in Seahorse XF-24 microplates and treated for 16 hours with BALF pooled from five mice instilled intratracheally with saline or LPS. The media were then replaced with FAO assay media supplemented with 150 mM palmitate-BSA and cultured for 1 hour, followed by sequential treatments with 3 mg/ml oligomycin, 6 mM FCCP, and 1 mM Rot and 0.5 mM Ant. Real-time OCR was recorded. n = 6 per group; mean 6 SEM. (E-F) MLE-12 cells were incubated for 16 hours with BALFs from mice instilled intratracheally with saline or LPS for 24 hours. The mRNA (E) and/or protein (F) levels of indicated genes were determined by real-time PCR and Western blotting. (E) n = 3; mean 6 SD; *P , 0.05, **P , 0.01, ***P , 0.001 compared with saline group. FCCP = Carbonyl cyanide 4-(trifluoro) methoxyphenylhydrazone.
Biosciences), and streptavidin-conjugated magnetic beads (Promega) to deplete myeloid and lymphoid cells, endothelial cells, and mesenchymal fibroblasts.
Determination of Intracellular ATP Levels
Intracellular ATP levels were determined using Luminescent ATP Detection Assay Kit (Abcam) according to the manufacturer's instructions.
Determination of AEC Apoptosis
AECs were incubated with annexin V-FITC and propidium iodide from an Apoptosis Detection Kit (BD Biosciences) according to the manufacturer's instructions, and cell apoptosis was analyzed by flow cytometry. Percentages of annexin V and propidium iodide-positive cells were determined by flow cytometry. , with control groups as onefold.
Western Blotting
Western blotting was performed as previously described (27) . Mouse anti-bactin antibody was from Sigma-Aldrich. Mouse anti-PGC-1a antibody was from EMD Millipore. Rabbit anti-CPT1A antibody was from Proteintech. Rabbit anticleaved caspase-3 was from Cell Signaling Technology.
Lentivirus Preparation
The full-length cDNA of mouse PGC-1a was purchased from Dharmacon. The open reading frame (ORF) of PGC-1a was amplified by PCR and subcloned into the BamH1 and Not1 sites of lentiviral vector pCDH-EF1-MCS (System Biosciences). HEK-293T cells were co-transfected with pCDH-EF1-MCS or pCDH-EF1-PGC-1a and the third generation packaging constructs. Cells were cultured according to the manufacturer's instructions (System Biosciences). Media that contained lentivirus were collected at Days 3 and 4 after transfection. For transduction, MLE-12 cells were incubated with the lentivirus-containing media (50% of total culture media).
ELISA
Levels of proinflmammatory cytokines were determined using DuoSet ELISA development kits (R&D Systems) according to the manufacturer's instructions. The media were then replaced with FAO assay media supplemented with 150 mM palmitate-BSA and cultured for 1 hour, followed by sequential treatments with 3 mg/ml oligomycin, 6 mM FCCP, and 1 mM rotenone and 0.5 mM antimycin A. Real-time oxygen consumption rate was recorded. n = 6 per group; mean 6 SEM. con = control; MEM = Eagle's minimum essential medium. Figure 1A ). The reduced expression of some of these genes in the AECs of ALI lungs was confirmed by real-time PCR as well as Western blot analysis ( Figures 1B and 1C ). In addition, we found that these mediators in the whole lungs of ALI mice were downregulated to levels comparable to those in the AECs ( Figure 1D ), suggesting that AECs are the primary targets of the metabolic dysregulations. These data also indicate that impaired FAO and mitochondrial bioenergenesis in AECs may contribute to the pathogenesis of ALI.
MLE-
AECs Use both Glucose and Fatty Acids
Despite the implication of the impaired FAO and mitochondrial bioenergenesis in ALI pathology, metabolic programs in AECs have not been clearly delineated. There has been even less evidence of if or how individual metabolisms in AECs participate in the pathogenesis of pulmonary disorders associated with dysfunctions of these cells, including ALI. To characterize metabolic programs in AECs, we initially focused on the mitochondrial oxidations of two core nutrients (e.g., fatty acids and glucose) by using Seahorse Analyzer. As shown in Figure 2A , there was gradually increased OCR in primary mouse AECs while being fed with fatty acids in the form of palmitate conjugated to BSA. In contrast, OCR remained unchanged when the cells were supplied with BSA ( Figure 2A ). These data suggest that AECs readily use fatty acids that undergo mitochondrial oxidation. In addition, we found that AECs also demonstrated a robust glycolytic program. However, a large share of the program was channeled to produce the end-product lactate, instead of supplying the mitochondrial respiration, as evidenced by a spike in ECAR, accompanied by a moderate increase of OCR when the cells were fed with glucose ( Figure 2B ). Taken together, these data suggest that FAO constitutes an essential part of the metabolic programs in AECs.
FAO Is Impaired in AECs of Mice with LPS-induced ALI
To determine the role of AEC FAO in ALI, we isolated primary AECs from mice treated intratracheally with saline or LPS and measured real-time OCR in these cells. As shown in Figure 2C , although AECs from saline-treated mice demonstrated rapidly elevated OCR upon being fed with fatty acids, AECs from mice with LPS-induced ALI showed little response to fatty acids, indicative of markedly impaired FAO in these cells. Taken together, these data suggest that FAO impairment may mediate AEC dysfunctions in ALI.
Alveolar Epithelial Line MLE-12 Cells Use Fatty Acids, and FAO Is Impaired in MLE-12 Treated with BALF from ALI Mice
We have shown that primary mouse AECs conduct robust FAO, and this metabolic program is markedly diminished in AECs of Figure 5 .
(Continued). annexin V-FITC and propidium iodide (PI). Cell apoptosis was analyzed by flow cytometry (D). Percentages of apoptotic cells were plotted (E). (F and G)
MLE-12 cells were pretreated for 1 hour with 100 mM ETO, followed by incubation with 2 ng/ml mouse TNF-a for 16 hours. Cell apoptosis was analyzed by flow cytometry (F). Percentages of apoptotic cells were plotted (G). (D-G) n = 3; mean 6 SD; **P , 0.01, ***P , 0.001. (H) MLE-12 cells were transduced with control lentivirus or lentivirus that expressed mouse PGC-1a. Levels of PGC-1a were determined 1 day after transduction. (I) MLE-12 cells were transduced with control lentivirus or lentivirus that expressed mouse PGC-1a. The cells were then plated in Seahorse XF-24 microplates overnight. The media were then replaced with FAO assay media supplemented with 150 mM palmitate-BSA and cultured for 1 hour, followed by sequential treatments with 3 mg/ml oligomycin, 6 mM FCCP, and 1 mM Rot and 0.5 mM Ant. Real-time oxygen consumption rate was recorded. n = 6 per group; mean 6 SEM. (J) MLE-12 cells were transduced with control lentivirus or lentivirus that expressed mouse PGC-1a. The cells were treated with TNF-a overnight. The expression of the indicated genes were determined by real-time PCR. n = 3; mean 6 SD; *P , 0.05, **P , 0.01, ***P , 0.001. (K) The cell transduction and treatment were conducted as in J, and annexin V-FITC and PI assay performed. Percentages of apoptotic cells were plotted. n = 4; mean 6 SD; **P , 0.01, ***P , 0.001. ALI lungs. To delineate the regulatory mechanism and the functional outcome of FAO deficiency in AECs, we chose a well-established mouse AEC line, MLE-12, to serve as a cellular model for further investigations. We first examined fatty acid metabolism in these cells, and found that MLE-12 cells, just like the primary AECs, effectively used fatty acids through mitochondrial oxidation ( Figure 3A) . As expected, FAO in MLE-12 cells was notably diminished by the specific inhibitor of CPT1A, ETO ( Figure 3B ). In addition, we found that, also similar to that in the primary AECs, the glycolytic program in MLE-12 cells was largely ushered to lactate production, with a moderate destination for mitochondrial oxidation ( Figure 3C ). These data suggest that the metabolic programs in MLE-12 are comparable to those in the primary AECs.
To determine if the metabolic pathology in AECs of ALI mice could be replicated in vitro, we treated MLE-12 cells with BALFs from ALI mice, and found that OCR with FAO assay was diminished in these cells (Figure 3D ), suggestive of an impairment on FAO. The compromised OCR in MLE-12 treated with BALFs from ALI lungs could be attributed to downregulations of PGC-1a, CPT1A, LCAD, and MCAD in the cells (Figures 3E  and 3F ). Taken together, these findings suggest that FAO impairment in AECs of ALI lungs is an effect of local pathological settings.
Proinflammatory Cytokine TNF-a Inhibits FAO in AECs
We showed the FAO inhibitory activity of BALFs from ALI mice, we next reasoned that proinflammatory cytokines in the BALFs from these mice accounted for the downregulation of the key mediators in FAO and mitochondrial bioenergenesis and the ensuing inhibition of FAO. To test this hypothesis, we treated MLE-12 cells with proinflammatory cytokine, TNF-a, and found that the expression of PGC-1a, CPT1A, LCAD, and MCAD was all decreased in the TNF-a-treated cells ( Figures 4A and 4B) . Concordantly, we found that TNF-a markedly inhibited OCR in MLE-12 cells (Figure 4C ), suggestive of a compromised FAO. Taken together, these data suggest that the proinflammatory cytokines in the inflamed lungs lead to FAO defects in the AECs through downregulating the critical mediators in this metabolic program.
FAO Participates in AEC Bioenergenesis and Promotes AEC Survival
As cellular bioenergenesis is critical to cell survival and functional homeostasis, we next asked if FAO was essential to the bioenergetic output of AECs. We treated MLE-12 cells with ETO and found that ETO significantly decreased intracellular ATP levels ( Figure 5A ), indicative of a critical contribution of FAO to the AEC bioenergenesis. Furthermore, we found that MLE-12 treated with BALFs from ALI mice or TNF-a demonstrated markedly reduced intracellular ATP levels ( Figures 5B and 5C ), consistent with their inhibitions of FAO in the cells. Taken together, our data suggest that proinflammatory cytokines in the inflamed lungs impair AEC bioenergenesis through downregulating FAO in these cells.
Bioenergetic defect leads to cellular dysfunctions and death (8, 12) . In addition, AEC apoptosis is one of the pathological hallmarks of ALI lungs. This body of information led to the hypothesis that the compromised FAO in AECs participated in apoptosis of these cells in injured lungs. To test this, we treated MLE-12 cells with BALFs from ALI mice, and found that these cells demonstrated significantly elevated apoptosis as compared with those treated with normal BALFs (Figures 5D and 5E ).
We also found that TNF-a induced MLE-12 apoptosis (Figures 5F and 5G ). More importantly, TNF-a-induced MLE-12 apoptosis was significantly enhanced by the FAO inhibitor, ETO. Notably, although ETO inhibited ATP production, it alone failed to cause MLE-12 cell death, suggesting that the compromised bioenergenesis due to FAO impairment is not a sufficient, but a susceptible factor which aggravates AEC dysfunction in the inflamed lung, an environment enriched with proapoptotic inducers, such as TNF-a and reactive oxygen species. To further define the role of FAO in regulating TNFa-induced AEC apoptosis, we directly overexpressed the master FAO regulator, PGC-1a, in MLE-12 cells through lentiviral delivery of recombinant DNA constructs ( Figure 5H ). Likely as a result of overexpression, there was a markedly augmented OCR in these cells ( Figure 5I ), which was also consistent with the upregulation of the PGC-1a-dependent, critical FAO mediators, CPT1A, MCAD, and LCAD ( Figure 5J ). More importantly, we found that overexpression of PGC-1a demonstrated a very consistent, though modest protection from TNF-a-induced apoptosis ( Figure 5K ). Taken together, these findings suggest that the proinflammatory cytokines in the inflamed lungs promote AEC apoptosis by inhibiting FAO in these cells.
Ablation of AEC PGC-1a Aggravates LPS-induced ALI
PGC-1a is a master regulator of FAO and mitochondrial bioenergenesis (18, 23, 24, 29) . Given our findings that AECs in ALI lungs demonstrated markedly reduced expression of PGC-1a and impaired FAO, we reasoned that AEC PGC-1a was critical to the fitness of these cells and participated in ALI pathology. To test this hypothesis, we established conditional knockout mice with ablation of PGC-1a in AECs (AEC PGC-1a
2/2
). We first validated that Figure 6 . (Continued). PGC-1a 2/2 mice were instilled intratracheally with saline or LPS (2 mg/kg in 50 ml saline). At 24 hours after treatment, the mice were killed and BALF (0.5 ml for 3 times/mouse) and lungs collected. BALF was centrifuged to collect supernatants and cell pellets. Red blood cells in the cell pellets were lysed. The whole lungs were homogenized in 3-ml protein extraction buffer. Levels of indicated proinflammatory cytokines in BALF (C) and lung extracts (D) were determined by ELISA. (E and F) Total protein levels (E) and leukocyte numbers (F) in the BALFs. *P , 0. 
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PGC-1a level was reduced, as expected, in AECs from these mice after induction of ablation of the floxed alleles by tamoxifen ( Figure 6A ). The expression of PGC1a-dependent CPT1A and MCAD was also decreased in these cells ( Figure 6A) . Consistent with the role of these mediators in FAO, we found that OCR with FAO assay in AEC PGC-1a 2/2 cells was markedly decreased compared with that in AEC PGC-1a fl/fl controls ( Figure 6B ). We found that there was no obvious inflammation or injury in the lungs of saline-treated AEC PGC-1a 2/2 mice ( Figures 6C-6E) , indicative of nonessential function of AEC PGC-1a to pulmonary homeostasis. However, compared with the wild-type PGC-1a fl/fl mice, AEC PGC1a 2/2 animals demonstrated aggravated LPS-induced lung injury, as evidenced by increased levels of proinflammatory cytokines in BALFs and lungs, and augmented lung protein leaks and leukocyte infiltrations ( Figures 6C-6G) . Furthermore, we found that there was enhanced AEC apoptosis in LPS-treated AEC PGC-1a 2/2 mice, indicated by more evident staining of cleaved caspase 3 in the AECs of these animals ( Figure 6H ), consistent with the elevated susceptibility to apoptosis of MLE-12 cells in vitro when FAO was impaired. Taken together, these data suggest that PGC-1a is essential to AEC survival and homeostasis in the setting of ALI.
The Activator of PPAR-a/PGC-1a Cascade, Fenofibrate, Attenuates LPS-induced ALI in Mice
As PGC-1a acts together with PPAR-a to regulate FAO (30), we examined the effect of the PPAR-a agonist, fenofibrate, on LPSinduced ALI. As shown in Figures 7A-7C , administration of fenofibrate 4 hours after intratracheal LPS significantly attenuated LPS-induced ALI, as evidenced by reduced proinflammatory cytokine levels, leukocyte numbers, and protein levels in BALFs from these mice. To determine if the protective effect of fenofibrate was associated with FAO, we examined the expression of those FAO mediators in AECs purified from mice treated with this drug, and found that the levels of PPARa CPT1A, MCAD, and LCAD were significantly increased in these cells compared with those from vehicletreated animals ( Figure 7D ). Consistent with the elevated expression of these FAO mediators, there was a trend of reversal of the impaired FAO in AECs from ALI mice that received fenofibrate ( Figure 7E ). Taken together, these data in general support the notion that augmentation of AEC FAO is beneficial in ALI, although we caution against a stretched interpretation because fenofibrate is likely to have PPARa/PGC-1a-or FAO-independent activities. Figure 7 . The activator of PGC-1a/peroxisome proliferator-activated receptor-a cascade, fenofibrate, attenuates LPS-induced ALI in mice. C57BL/6 mice (8 wk old) were instilled intratracheally with saline or LPS (2 mg/kg in 50 ml saline). At 4 hours after the intratracheal treatment, the mice were injected intraperitoneally with vehicle or fenofibrate (100 mg/kg body weight). At 24 hours after saline or LPS instillation, the mice were killed and BALF (0.5 ml for 3 times/mouse) collected. BALF was centrifuged to collect supernatants and cell pellets. Red blood cells in the cell pellets were lysed. Levels of indicated proinflammatory cytokines (A), protein concentrations (B), and total leukocyte numbers (C) in BALF was determined. (A-C) n = 3, 5, 3, 5 mice, respectively; mean 6 SEM; *P , 0.05, **P , 0.01, ***P , 0.001. (D) Primary AECs were purified from mice injected intraperitoneally with vehicle or fenofibrate. Levels of the indicated genes in the cells were determined. n = 3; mean 6 SEM; *P , 0.05, **P , 0.01. (E) Primary AECs purified from saline-or LPS-instilled mice injected intraperitoneally with vehicle or fenofibrate were seeded in Seahorse XF-24 microplates and incubated with substrate-limited media for 3 hours. Basal OCR was then recorded before BSA or palmitate-BSA was injected into the wells. After injection, OCR was continuously recorded until stable levels were reached. Fold change in average OCR values were plotted. n = 4, 4, 2; ***P , 0.001.
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Nevertheless, these findings suggest that FAO could become a novel therapeutic target for treating this lung disorder.
Discussion
Although AEC dysfunctions have been well recognized to have critical contributions to ALI pathologies (15, 31) , there is a scarcity of studies that investigate the underlying mechanisms from the standpoint of cellular metabolism. We provide the first line of evidence that AECs effectively conduct FAO. Our data show that AEC FAO has a critical role in maintaining the functional homeostasis of these cells. Our study thus establishes the dysregulation of FAO as a metabolic phenotype for ALI. Focusing of this study on AEC FAO was literally guided by our RNA-seq analysis that revealed the reduced expression of important mediators in FAO and mitochondrial bioenergenesis. Although scientifically rationalized, we are aware of the fact that other metabolic programs, such as those involving amino acids, may also participate in AEC dysfunctions in ALI. In addition, not all mediators associated with metabolic programs are affected at the transcriptional level, which is the only information that the RNA-seq analysis could reveal. Nevertheless, this study opens a new avenue of investigations into interactions of metabolism and cellular functions, particularly in AECs, in lung disorders.
We have found that AEC PGC-1a is significantly downregulated in ALI lungs. Furthermore, ablation of AEC PGC-1a aggravated LPS-induced ALI. Although PGC-1a is a key regulator of FAO, it has a myriad of additional regulatory functions, such as controlling mitochondrial biogenesis, oxidative phosphorylation, gluconeogenesis, and glycogenolysis, whereby it regulates the catabolism of other nutrients, including glucose (32, 33) . Therefore, the effect of PGC-1a downregulation on AEC bioenergenesis may not be entirely caused by the impaired FAO, but also by diminished glucose oxidation in these cells. This speculation is, in general, supported by previous studies showing that there is elevated glycolysis in inflamed lungs, a metabolic reprogramming response that is normally used to compensate for insufficient mitochondrial oxidative phosphorylation activity (34) . However, the exact contributions of fatty acids and glucose oxidation to AEC bioenergenesis may only be determined with carbon isotope tracing techniques. Along similar lines, augmented LPS-induced lung injury in mice with ablation of AEC PGC-1a may be derived from AEC dysfunction caused by defective mitochondrial oxidative phosphorylation that undermines both fatty acids and glucose catabolism.
We showed that BAFL from ALI lungs decreased the expression of the key mediators in FAO and mitochondrial bioenergenesis, including PGC-1a, CPT1A, MCAD, and LCAD. We also found that TNF-a, one of the predominant proinflammatory cytokines in ALI lungs, achieved a similar effect. Although it is certain that the downregulation is at least at the transcriptional level, the regulatory mechanism remains unknown. Given that our data suggest that the impairment in FAO in AECs is an effect secondary to the production of inflammatory cytokines in ALI, the delineation of how proinflammatory signaling events inhibit the expression of these key mediators may help to identify the means to uncouple lung inflammation and AEC dysfunction, which could become novel therapeutics to treat this disorder.
We have shown that FAO is significantly impaired in AECs of ALI lungs, and the defective FAO leads to diminished bioenergenesis and apoptosis in these cells. These findings solidly implicate FAO in AEC dysfunction and ALI pathogenesis. However, other types of pulmonary cells, such as endothelial cells and macrophages, may also conduct active FAO. Indeed, there has been plenty of evidence that FAO is critical to the development of an antiinflammatory M2 phenotype in macrophages (35, 36) . In addition, FAO was recently shown to be required for endothelial cell proliferation (37) . Given that the dysfunction of these two types of cells also demonstrate pivotal participation in ALI pathogenesis by causing alveolar-capillary barrier destruction and cytokine storm (38) (39) (40) (41) , it is reasonable to speculate that some therapeutic efficacies of boosting FAO in the lung in ALI may be derived from FAO-augmented antiinflammation and proproliferation in pulmonary macrophages and microvascular endothelial cells, respectively. These two events have been shown to be immensely beneficial in the treatment of experimental ALI in animal models (42) (43) (44) . Therefore, it remains a very interesting direction forward to delineate the role of FAO in pulmonary macrophages and endothelial cells in the pathogenesis of ALI. n
